Lineage Cell Therapeutics, Inc. Common Stock (LCTX) SG&A Expenses & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · SG&A Expenses

LCTX SG&A Expenses

Latest reported$19.35Mperiod endingJun 30, 2026

LCTX SG&A Expenses ($400.00K → $19.35M)

Annual SG&A Expenses

High-resolution chart · PNG

LCTX sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock SG&A Expenses — Annual fiscal periods (USD)
Period ending	SG&A Expenses (USD)
Dec 31, 2025	18,460,000
Dec 31, 2024	18,171,000
Dec 31, 2023	17,302,000
Dec 31, 2022	22,508,000
Dec 31, 2021	18,212,000
Dec 31, 2020	15,571,000
Dec 31, 2019	24,031,000
Dec 31, 2018	24,726,000
Dec 31, 2017	19,922,000
Dec 31, 2016	28,426,000
Dec 31, 2015	29,134,000
Dec 31, 2014	17,556,102
Dec 31, 2013	15,558,674
Dec 31, 2012	10,365,045
Dec 31, 2011	9,341,502
Dec 31, 2010	5,640,409
Dec 31, 2009	2,476,447
Dec 31, 2008	2,620,210
Dec 31, 2007	1,300,630
Dec 31, 2006	1,491,622
Dec 31, 2005	1,395,925
Dec 31, 2004	1,484,372
Dec 31, 2003	1,260,712
Dec 31, 2002	1,318,159
Dec 31, 2001	1,961,342
Dec 31, 2000	1,779,931
Dec 31, 1999	1,896,690
Dec 31, 1998	700,000
Jun 30, 1998	1,200,000
Jun 30, 1996	2,100,000
Jun 30, 1995	800,000
Jun 30, 1994	900,000
Jun 30, 1993	800,000
Jun 30, 1992	400,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.